Among the key mediators of inflammation-associated cancer are the nuclear factor-kappa B (NF-κB) signaling pathway and cyclooxygenase-2 (COX-2), both of which are frequently dysregulated in various malignancies and represent important therapeutic targets [49,50]. The gene discussed is PTGS2; the disease is cancer.